Caption Management’s Novo Nordisk NVO Stock Holding History

Caption Management’s Portfolio NVO Stock Details NVO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.94M	Buy	103,132 +42,532	+70%	+$1.83M	0.02%	584
2026 Q1	$2.23M	Sell	60,600 -19,571	-24%	-$927K	0.01%	794
2025 Q4	$4.08M	Buy	+80,171	New	+$4.1M	0.03%	581
2025 Q1	–	Sell	-101,750	Closed	-$8.4M	–	1882
2024 Q4	$8.75M	Buy	101,750 +88,355	+660%	+$9.55M	0.08%	226
2024 Q3	$1.59M	Buy	+13,395	New	+$1.79M	0.03%	641
2023 Q4	–	Sell	-25,000	Closed	-$2.47M	–	1558
2023 Q3	$2.27M	Buy	+25,000	New	+$2.2M	0.04%	543
2022 Q3	–	Sell	-1,200	Closed	-$67K	–	1752
2022 Q2	$67K	Buy	+1,200	New	+$66.6K	﹤0.01%	1323
2021 Q3	–	Sell	-40,000	Closed	-$1.68M	–	1702
2021 Q2	$1.68M	Buy	+40,000	New	+$1.55M	0.02%	744
2018 Q4	–	Sell	-26,800	Closed	-$632K	–	568
2018 Q3	$632K	Buy	+26,800	New	+$654K	0.03%	391

Other funds holding NVO

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Caption Management's NVO Position: Q2 2026 in Review

Caption Management increased its Novo Nordisk (NVO) stake by 70% in Q2 2026, buying an estimated $1.83M and bringing the position to 103,132 shares worth $4.94M. The position accounts for 0.02% of the portfolio, ranked #584.

Caption Management first reported a position in NVO in Q3 2018 and has held it in 9 quarters since. The position peaked at $8.75M in Q4 2024. 1,353 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

Caption Management held 103,132 shares of Novo Nordisk worth $4.94M as of Q2 2026.
Caption Management bought 42,532 Novo Nordisk shares in Q2 2026, an estimated $1.83M.
Novo Nordisk made up 0.02% of Caption Management's portfolio in Q2 2026, its #584 holding.
Caption Management first reported a position in Novo Nordisk in Q3 2018 and has held it in 9 quarters since.
Caption Management's Novo Nordisk position peaked at $8.75M in Q4 2024.
1,353 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Caption Management's 13F filing for Q2 2026, filed 14 Aug 2026.